Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study

Cristina RIGAMONTI, Micol Giulia Cittone, Carla De Benedittis, Eleonora Rizzi, Giuseppe Francesco Casciaro, Mattia BELLAN, Pier Paolo SAINAGHI, Mario PIRISI

Research output: Contribution to journalArticlepeer-review

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus responsible for a variety of clinical manifestations that, besides the lungs, can involve several other organs, leading to both mild and severe complications.1–3

Original languageEnglish
JournalClinical Gastroenterology and Hepatology
DOIs
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study'. Together they form a unique fingerprint.

Cite this